4-{2-[4-(Benzo[1,3]dioxole-5-sulfonyl)-phenyl]-tetrahydro-furan-2-yl}-1'-(propane-1-sulfonyl)-[1,4']bipiperidinyl

ID: ALA92569

Chembl Id: CHEMBL92569

PubChem CID: 44325013

Max Phase: Preclinical

Molecular Formula: C30H40N2O7S2

Molecular Weight: 604.79

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCS(=O)(=O)N1CCC(N2CCC(C3(c4ccc(S(=O)(=O)c5ccc6c(c5)OCO6)cc4)CCCO3)CC2)CC1

Standard InChI:  InChI=1S/C30H40N2O7S2/c1-2-20-40(33,34)32-17-12-25(13-18-32)31-15-10-24(11-16-31)30(14-3-19-39-30)23-4-6-26(7-5-23)41(35,36)27-8-9-28-29(21-27)38-22-37-28/h4-9,21,24-25H,2-3,10-20,22H2,1H3

Standard InChI Key:  PFZBZEAIVHQPHF-UHFFFAOYSA-N

Associated Targets(Human)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptors; M1 & M2 (498 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptors; M2 & M3 (708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 604.79Molecular Weight (Monoisotopic): 604.2277AlogP: 4.17#Rotatable Bonds: 8
Polar Surface Area: 102.45Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.39CX LogP: 3.08CX LogD: 2.79
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.44Np Likeness Score: -0.69

References

1. Boyle CD, Chackalamannil S, Chen LY, Dugar S, Pushpavanam P, Billard W, Binch H, Crosby G, Cohen-Williams M, Coffin VL, Duffy RA, Ruperto V, Lachowicz JE..  (2000)  Benzylidene ketal derivatives as M2 muscarinic receptor antagonists.,  10  (24): [PMID:11133078] [10.1016/s0960-894x(00)00553-9]
2. Wu YJ, Meanwell NA..  (2021)  Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.,  64  (14.0): [PMID:34213340] [10.1021/acs.jmedchem.1c00790]

Source